Similar Search Results

Audit of Diabetes-Dependent Quality of Life (ADDQoL) [Chinese Version for Singapore] Questionnaire: Reliability and Validity among Singaporeans with Type 2 Diabetes Melli...

Soon, Swee Sung.; Goh, Su Yen.; Bee, Yong Mong.; Poon, … - In: Applied Health Economics and Health Policy 8 (2010) 4, pp. 239-249

Background: The Audit of Diabetes-Dependent Quality of Life (ADDQoL) questionnaire is an individualized instrument that measures the impact of diabetes mellitus on quality of life (QOL). With the worldwide increase in the number of Chinese people diagnosed with diabetes, we anticipated that a...

Persistent link: https://www.econbiz.de/10008462724

Patient-Reported Outcomes in Rheumatoid Arthritis: Assessing the Equivalence of Electronic and Paper Data Collection

Tiplady, Brian; Goodman, Kirsteen; Cummings, Geraldine; … - In: The Patient: Patient-Centered Outcomes Research 3 (2010) 3, pp. 133-143

Background: The questionnaires used in clinical research have often been developed and validated using paper, and in such cases it is necessary to show that the electronic versions are equivalent to the originals. Objective: To determine if electronic versions of questionnaires assessing...

Persistent link: https://www.econbiz.de/10008495171

Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis

Adams, Roisin; Walsh, Cathal; Veale, Douglas; … - In: PharmacoEconomics 28 (2010) 6, pp. 477-487

Background: The growth of economic analyses and in particular cost-utility analyses (CUA), which use the QALY as a measure of outcome, has heightened the interest in the methodologies used to calculate the QALY. The EQ-5D has produced quite different utility values from that of the SF-6D. This...

Persistent link: https://www.econbiz.de/10008467351

Measuring Quality of Life for Certain Events versus Pre-Specified Points in Time

Neyt, Mattias - In: PharmacoEconomics 28 (2010) 3, pp. 171-174

Persistent link: https://www.econbiz.de/10008521838

The Authors' Reply

Kind, Paul; Macran, Sue - In: PharmacoEconomics 24 (2006) 3, pp. 294-296

Persistent link: https://www.econbiz.de/10005448971

Missing Data Imputation in Quality-of-Life Assessment: Imputation for WHOQOL-BREF

Lin, Ting Hsiang - In: PharmacoEconomics 24 (2006) 9, pp. 917-925

Introduction: This study investigated the effects of imputing missing data in the WHO Quality of Life Abbreviated Questionnaire (WHOQOL-BREF). The imputation results from both the item and domain levels were compared and the impact of the missing data rate and the number of items included for...

Persistent link: https://www.econbiz.de/10005449001

Productivity Costs in Health-State Valuations: Does Explicit Instruction Matter?

Krol, Marieke; Brouwer, Werner; Sendi, Pedram - In: PharmacoEconomics 24 (2006) 4, pp. 401-414

Background: There has been considerable debate on whether productivity costs should be captured in the numerator or the denominator of the cost-effectiveness ratio. That debate cannot be resolved on the basis of theoretical arguments alone because the final choice also depends on what is...

Persistent link: https://www.econbiz.de/10005449076

The Authors' Reply

Milne, Richard J.; Heaton-Brown, Kathy H.; Hansen, Paul; … - In: PharmacoEconomics 24 (2006) 4, pp. 416-417

Persistent link: https://www.econbiz.de/10005449108

The Use of QALY Weights for QALY Calculations: A Review of Industry Submissions Requesting Listing on the Australian Pharmaceutical Benefits Scheme 2002-4

Scuffham, Paul A.; Whitty, Jennifer A.; Mitchell, Andrew; … - In: PharmacoEconomics 26 (2008) 4, pp. 297-310

Background: QALYs combine survival and health-related quality of life (QOL) into a single index, enabling judgements about the relative value for money of healthcare interventions. Objective: To investigate the methods used for estimating QALY weights included in submissions by industry for...

Persistent link: https://www.econbiz.de/10005449110

Eliciting Social Preference Weights for Functional Assessment of Cancer Therapy-Lung Health States

Kind, Paul; Macran, Susan - In: PharmacoEconomics 23 (2005) 11, pp. 1143-1153

Background: The Functional Assessment of Cancer Therapy-Lung (FACT-L) is a multidimensional measure of quality of life developed for use in the evaluation of interventions in lung cancer. Objective: To develop a set of utility weights that could be used to convert FACT-L into a single index...

Persistent link: https://www.econbiz.de/10005449277